Neurobiology of Aging
Volume 24, Issue 1 , Pages 85-94 , January 2003

Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer’s disease in relation to dementia severity: evidence for early neocortical degeneration

  • S.J Teipel

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +11-49-89-5160-5860; fax: +11-49-89-5160-5865.
  • ,
  • W Bayer

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
  • ,
  • G.E Alexander

      Affiliations

    • MRI Morphology Core, Arizona Alzheimer’s Disease Research Center and Department of Psychology, Arizona State University, Tempe, AZ, USA
  • ,
  • A.L.W Bokde

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
  • ,
  • Y Zebuhr

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
  • ,
  • D Teichberg

      Affiliations

    • Section on Brain Physiology and Metabolism, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  • ,
  • F Müller-Spahn

      Affiliations

    • Department of Psychiatry, University of Basel, Basel, Switzerland
  • ,
  • M.B Schapiro

      Affiliations

    • Department of Pediatric Neurology, Children Hospital Medical Center, Cincinatti, OH, USA
  • ,
  • H.-J Möller

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
  • ,
  • S.I Rapoport

      Affiliations

    • Section on Brain Physiology and Metabolism, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  • ,
  • H Hampel

      Affiliations

    • Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Nussbaumstr. 7, 80336 Munich, Germany
    • Co-corresponding author.

Received 15 August 2001 ,Revised 1 February 2002 ,Accepted 7 March 2002.

References 

  1. Bamber D. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J. Math Psychol. 1975;12:387–415
  2. Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, et al.  In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease. Neuroimage. 2001;14:298–309
  3. Begg CB. Advances in statistical methodology for diagnostic medicine in the 1980’s. Statist. Med. 1991;10:1887–1895
  4. Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, et al.  The histological validation of post mortem magnetic resonance imaging—determined hippocampal volume in Alzheimer’s disease. Neuroscience. 2000;95:721–725
  5. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, De Leon MJ, et al.  Neurofibrillary pathology—correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging. 1996;17:909–919
  6. Bookstein FL. ‘Voxel-based morphometry’ should not be used with imperfectly registered images. Neuroimage. 2001;14:1454–1462
  7. Braak H, Griffing K, Braak E. Neuroanatomy of Alzheimer’s disease. Alzheimer’s Res. 1997;3:235–247
  8. De Lacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J. Neuropath Exper. Neurol. 1985;44:578–591
  9. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging. 2001;22:529–539
  10. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845
  11. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, et al.  Positron emission tomography in Alzheimer’s disease. Neurology. 1986;36:879–887
  12. Duvernoy HM. The human hippocampus: functional anatomy, vascularization and serial sections with MRI. Heidelberg, Germany: Springer; 1998.
  13. Folstein MF, Folstein SE, McHugh PR. Mini-mental-state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  14. Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN. Imaging of onset and progression of Alzheimer’s disease with voxel–compression mapping of serial magnetic resonance images. Lancet. 2001;358:201–205
  15. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer’s disease. J. Mag. Reson. Imag. 1997;7:1069–1075
  16. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, et al.  Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with (18F)Fluorodeoxyglucose. J. Comput. Assist. Tomogr. 1983;7:590–598
  17. Green D, Swets J. Signal detection theory and psychophysics. New York: Wiley, 1966.
  18. Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer’s disease: perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy- evidence from studies with MRI, EEG and PET. J Neural Transm Suppl, 2002, in press.
  19. Hampel H, Teipel SJ, Bayer W, Alexander GE, Schwarz R, Schapiro MB, et al.  Age-transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer’s disease. J. Neurol. Sci. 2002;194:15–19
  20. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Hippius H, Möller HJ, et al.  Corpus callosum measurement is an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer’s disease. Ann. NY Acad. Sci. 2000;903:470–477
  21. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro M, et al.  Corpus callosum atrophy is a possible indicator for region and cell type specific neuronal degeneration in Alzheimer disease: an MRI analysis. Arch. Neur. 1998;55:193–198
  22. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology. 1983;148:839–843
  24. Heun R, Mazanek M, Atzor KR, Tintera J, Gawehn J, Burkart M, et al.  Amygdala-hippocampal atrophy and memory performance in dementia of Alzheimer type. Dement. Geriatr. Cogn. Disord. 1997;8:329–336
  25. Jack CR, Petersen RC, O’Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology. 1992;42:183–188
  26. Janowsky JS, Kaye JA, Carper RA. Atrophy of the corpus callosum in Alzheimer’s disease versus healthy aging. J. Am. Ger. Soc. 1996;44:798–803
  27. Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DGM, Rapoport SI, et al.  Volumes of medial temporal lobe structures in patients with Alzheimer’s disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry. 1998;43:60–68
  28. Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, et al.  High resolution PET studies in Alzheimer’s disease. Neuropsychopharmacology. 1991;4:35–46
  29. Laissy JP, Patrux B, Duchateau C, Hannequin D, Hugonet P, Ait-Yahia H, et al.  Midsagittal MR measurements of the corpus callosum in healthy subjects and diseased patients: a prospective survey. AJNR. 1993;14:145–154
  30. Lehéricy S, Baulac M, Chiras J, Piérot L, Martin N, Pillon B, et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer’s disease. Am. J. Neuroradiol. 1994;15:927–937
  31. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo J-P, Steinling M. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer’s disease and normal aging. Arch. Neurol. 1990;47:524–527
  32. Lyoo K, Satlin A, Lee CK, Renshaw PF. Regional atrophy of the corpus callosum in subjects with Alzheimer’s disease and multi-infarct dementia. Psychiatry Res.: Neuroimag. Sect. 1997;74:63–72
  33. Mann DMA, Esiri MM. The site of the earliest lesion in Alzheimer’s disease. N. Eng. J. Med. 1988;318:789–790
  34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34:939–944
  35. Metz CE. Basic principles of ROC analysis. Semin. Nucl. Med. 1978;8:283–298
  36. Nagy Z, Jobst KA, Esiri MM, Morris JH, King EM-F, MacDonald B, et al.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer’s disease: clinicopathological correlations using three sets of pathologic diagnostic criteria. Dementia. 1996;7:76–81
  37. Pandya DN, Karol EA, Heilbronn D. The topographical distribution of interhemispheric projections in the corpus callosum of the rhesus monkey. Brain Res. 1971;32:31–43
  38. Pandya DN, Seltzer B. The topography of commissural fibres. In: Lepre F, Ptito M, Jasper HH, editors. Two Hemispheres- One Brain: Functions of the Corpus Callosum, New York, NY: Alan R Liss Inc 1986:47–73.
  39. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, et al.  Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychol Med. 1997;27:221–229
  40. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 2001;58:1395–1402
  41. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, et al.  Loss of connectivity in Alzheimer’s disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry. 2000;69:528–530
  42. Schaltenbrand G, Spuler H, Wahren W. Electroanatomy of the corpus callosum radiation according to the facts of stereotactic stimulation in man. Z. Neurol. 1970;198:79–92
  43. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJP, Vermersch P, et al.  A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 1993;114:7–12
  44. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme; 1988.
  45. Tan YL, Chen BH, Yang JD, Zhang J, Wang YC, Chai SH, et al.  Localization of functional projections from corpus callosum to cerebral cortex. Clin. Med. J. 1991;104:851–857
  46. Teipel SJ, Hampel H, Alexander GE, Schapiro MB, Horwitz B, Teichberg D, et al.  Dissociation between white matter pathology and corpus callosum atrophy in Alzheimer’s disease. Neurology. 1998;51:1381–1385
  47. Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, et al.  Region-specific corpus callosum atrophy correlates with regional pattern of cortical glucose metabolism in Alzheimer’s disease. Arch. Neurol. 1999;56:467–473
  48. Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, et al.  Progression of corpus callosum atrophy in Alzheimer’s disease. Arch. Neurol. 2002;59:243–248
  49. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, et al.  Cortical change in Alzheimer’s disease detected with a disease-specific population-based brain atlas. Cereb. Cortex. 2001;11:1–16
  50. Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, et al.  Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer’s disease. Arch. Neurol. 1993;50:1070–1074
  51. Yu-ling T, Bing-huan C, Jiong-da Y, Jun Z, Yi-chong W, Song-hai C, et al.  Localization of functional projections from corpus callosum to cerebral cortex. Clin. Med. J. 1991;104:851–857

PII: S0197-4580(02)00044-1

Neurobiology of Aging
Volume 24, Issue 1 , Pages 85-94 , January 2003